Aigen Investment Management’s Evolent Health EVH Stock Holding History

Aigen Investment Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,850	Closed	-$33.9K	–	629
2026 Q1	$33.9K	Buy	+14,850	New	+$47.1K	0.01%	495
2025 Q4	–	Sell	-54,701	Closed	-$463K	–	707
2025 Q3	$463K	Buy	+54,701	New	+$531K	0.07%	416
2023 Q2	–	Sell	-21,381	Closed	-$694K	–	814
2023 Q1	$694K	Buy	+21,381	New	+$676K	0.1%	254
2022 Q4	–	Sell	-35,759	Closed	-$1.28M	–	607
2022 Q3	$1.28M	Buy	+35,759	New	+$1.26M	0.18%	161
2022 Q2	–	Sell	-9,671	Closed	-$312K	–	587
2022 Q1	$312K	Buy	+9,671	New	+$253K	0.05%	361
2020 Q4	–	Sell	-40,603	Closed	-$504K	–	848
2020 Q3	$504K	Buy	+40,603	New	+$477K	0.06%	396

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Aigen Investment Management's EVH Position: Q2 2026 in Review

Aigen Investment Management sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 14,850 shares — an estimated $33.9K sold.

Aigen Investment Management first reported a position in EVH in Q3 2020 and held it in 6 quarters. The position peaked at $1.28M in Q3 2022. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Aigen Investment Management reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
Aigen Investment Management sold 14,850 Evolent Health shares in Q2 2026, an estimated $33.9K.
Aigen Investment Management first reported a position in Evolent Health in Q3 2020 and held it in 6 quarters.
Aigen Investment Management's Evolent Health position peaked at $1.28M in Q3 2022.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.